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Summary The role of genetic factors involved in the determination of risk of cutaneous malignant melanoma
(CMM) in humans remains unclear owing to genetic heterogeneity and reliance on simplistic models of
inheritance. Here, we report a statistical genetic analysis of cutaneous malignant melanoma in Sinclair swine
(SSCM), a unique animal model for human CMM. Using complex segregation analysis a two-locus model
involving an unknown major locus and a second locus that lies within or close to the swine leucocytic antigen
(SLA) complex jointly determine risk of SSCM in pedigreed animals. These loci also influence severity of
affection, accounting for approximately 20% of the phenotypic variation in quantitative tumour burden.
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The genetic determinants of cutaneous malignant melanoma
(CMM) are complex and not completely known. In humans
risk of CMM is a function of family history, naevus number
and size, skin and eye colour and environmental co-variates
such as exposure to solar radiation (Green and Swerdlow,
1989). While there is great interest in the dissection of the
genetic architecture of this important cancer, relatively few
studies have employed formal statistical segregation analysis
to examine the role of major genes in the inheritance of
CMM or CMM in relationship to dysplastic naevi syndrome
(DNS) or other related concomitants (Greene et al., 1983;
Bale et al., 1986; Blangero et al., 1992; Neuman et al., 1992;
Speer et al., 1992). The results from these studies are
heterogeneous, yielding evidence for either a dominant
major gene (Greene et al., 1983; Bale et al., 1986), or a
recessive gene (Blangero et al., 1992; Neuman et al., 1992;
Speer et al., 1992) that significantly alters risk of getting
CMM. Further statistical support ofmajor locus involvement
comes from linkage analyses that have also produced
discrepant results among studies. Linkage between a
combined CMM/DNS phenotype to chromosomal region
lp36 has been reported in some pedigrees (Bale et al., 1989)
and refuted in others Cannon-Albright et al., 1990; Gruis et
al., 1990). Additionally, a significant linkage between a locus-
influencing CMM risk and chromosome 9pl3-p22 has been
observed in another set of pedigrees (Cannon-Albright et al.,
1992). These apparently divergent results among studies
suggest that either the mode of inheritance for melanoma
expression varies across families (i.e. genetic heterogeneity) or
that multiple loci jointly determine risk of CMM. Both of
these possibilities indicate that more sophisticated models for
the inheritance of CMM need to be considered.
One approach to resolving the complex inheritance of
CMM is to examine it in an animal model in which genetic
heterogeneity and environmental factors can be experimen-
tally controlled. Studies of the freshwater fish genus,
Xiphophorus, have exploited the experimental control
inherent in animal studies to identify genetic loci-involved
melanoma tumorigenesis and its suppression (Schwab, 1987).
We have chosen to use a different animal model for
elucidating the genetics of melanoma. Cutaneous malignant
melanoma in Sinclair swine (SSCM) is a reproducible animal
model that resembles human CMM both histopathologically
(Millikin et al., 1973; Danes and Lynch, 1983) and
immunologically (Hook et al., 1983). However, unlike
CMM in humans most animals with SSCM exhibit lesions
at birth and multiple primary tumours occur frequently
(Tissot et al., 1987). Additionally, spontaneous regression of
tumours is relatively common in animals that survive to
puberty and is related to alterations of host cellular immunity
(Jones and Amoss, 1982).
SSCM was first shown to be heritable via selective
breeding experiments (Hook et al., 1979). Subsequently, we
presented preliminary evidence from classical segregation
analyses that at least two loci influence expression of SSCM,
including an unknown putative dominant tumour-initiator
locus and a locus that segregates with the swine leucocyte
antigen (SLA) complex (Tissot et al., 1987, 1989, 1993),
which is homologous to the HLA complex. In this paper, we
formally test this two-locus model as an explanation of the
distribution of melanoma at birth in a set of large Sinclair
swine pedigrees using an extension of complex segregation
analysis.
Materials and methods
Swine
The Sinclair swine herd was maintained at Texas A&M
University. This colony was founded from the offspring of six
gilts from the Sinclair Comparative Medical Research Farm
of the University of Missouri. The colony has remained
essentially closed to outside breeding since 1970, although
inbreeding has been actively avoided. To increase the genetic
diversity of the founding stock, an additional three boars
were introduced in 1986. All animals were maintained on a
diet of 14% hog chow (Producers Coop, Bryan, TX, USA)
and water ad libitum. Standard veterinary care was provided.
Melanoma assessment
Newborn pigs were visually examined for evidence of
melanomas. Pigs with one or more exophytic tumours at
birth were considered as affected. In a majority of these
animals all lesions were examined histopathologically and
their number and locations noted.
SLA typing
For each animal 20 ml of heparinised blood was obtained
using standard techniques. The blood samples were shipped
on wet ice to the University of Illinois at Chicago for typing.
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Haplotypic variation at the SLA locus was assessed using a
one-way mixed lymphocyte typing test as previously
described (Tissot et al., 1987). Four SLA-D haplotypes were
observed and have been arbitrarily defined as A, B, C and D.
Based on our previous results (Tissot et al., 1987, 1989, 1993)
we limited consideration of haplotypes in our statistical
analyses to B and a combined non-B haplotype class, which
we denote as X.
Complex segregation analysis
Complex segregation analysis was performed using the
computer program PAP (Hasstedt, 1989), incorporating
modified penetrance and transmission subroutines that we
have developed. For a given model likelihoods on pedigrees
were calculated using the Elston-Stewart algorithm (Elston
and Stewart, 1971). To obtain maximum likelihood estimates
of model parameters numerical maximisation of the like-
lihood was achieved using GEMINI as the optimisation
subroutine (Lalouel, 1979). Melanoma affection status was
modelled using the class A regressive logistic approach of
Bonney (1986) extended to allow for two-locus effects,
including epistasis on the logistic scale (Blangero et al.,
1990). Both major genes (or major factors in the more
general case) and residual familial effects (separate regression
coefficients on sire and dam affection status) were permitted.
When a major gene is present SSCM risk was assumed to be
a partial function of the underlying major locus genotypes.
Because of the preliminary evidence of the SLA system's
involvement in risk of melanoma, we included simultaneous
consideration of this 'measured' locus in all analyses.
Therefore, we modelled the probability of affection status
as a function of an unknown major gene and SLA genotype.
We tested for the presence of a major locus, given the SLA
locus, using likelihood ratio tests. Our testing strategy
followed standard procedures (Lalouel et al., 1983) in which
a general model with arbitrary transmission probabilities (for
the major locus) is estimated and then compared with nested
submodels in which various constraints are placed on the
parameters. For example, one locus transmission probabil-
ities (e.g. z A, and Taa, which represent probabilities that a
parent with genotype AA (or Aa, aa) passes the A allele to an
offspring) are estimated in the general model. The adequacy
of the mixed Mendelian model in which the Ts are assumed to
take their Mendelian expectations (i.e. TAA = 1, TAa =0.5,
Taa=0) can be assessed by comparison with the more general
model using likelihood ratio tests. Additional models
considered included an environmental model in which
transmission of the major factor was random
(TAA =TAa=T.aa) but including residual familial effects, a one-
locus Mendelian model without an SLA effect, a one-locus
model with only an SLA effect, a familial model with only
sire and dam regression effects and random environmental
effects and a sporadic model that includes no transmissable
component. The major locus hypothesis is considered
acceptable only when it is not significantly worse fitting
than the general model and when the environmental model
can be statistically rejected.
Once a two-locus Mendelian model was established
additional testing was performed to reduce the model to its
most parsimonious form. Epistatic effects were examined
using a likelihood ratio test (Blangero et al., 1990) and
various structural models of Mendelian inheritance (i.e.
dominant vs recessive vs co-dominant) were evaluated.
After selection of a parsimonious genetic model estimates
of the penetrance for each two-locus genotype were obtained
by transformation to the probability scale from the logistic
scale. Standard errors for each genotype-specific penetrance
were obtained from the error co-variance structure of the
estimated parameters using a Taylor series approximation.
Linkage analysis
To test for potential non-independence between the SLA
locus and the putative major locus we extended the model to
include possible linkage between the major locus and the
SLA locus via two additional parameters, recombination
frequency and standardised gametic disequilibrium. Max-
imum likelihood estimates of these two parameters were
obtained simultaneously with all additional penetrance
parameters. A profile lod score function was obtained by
evaluating the likelihood of a series of recombination
fractions across the interval (0, 0.50) after simultaneous
estimation of all other model parameters. This procedure
leads to less-biased estimates of recombination and minimises
errors of inference.
Genetic effects on tumour burden
To assess the effect on the two loci on tumour burden, we
calculated the posterior probabilities of being a given
genotype for each animal based on the estimated model
parameters and all pedigree relationships. Using the genotype
probability estimator approach (Hasstedt and Moll, 1989),
we estimated the mean number of tumours for each genotype
using those animals for which tumour burden data were
available. The relative variance in tumour burden accounted
for by the two loci was calculated and its standard error (and
significance) evaluated using the jackknife method (Miller,
1974).
Results
Swine pedigrees usedfor segregation and linkage studies
The outbred swine pedigrees used in the genetic analyses were
complex, including both multiply mated sires and dams.
Table I shows the distribution ofanimals by pedigree. A total
of 619 animals with known melanoma status could be placed
in 12 pedigrees that correspond to large paternal half
sibships. An addition 147 animals provided essential
pedigree links. Pedigree sizes varied from 2 to 195 animals
with known melanoma status. Mean pedigree size was 51.6.
There were 81 full sibships ranging in size from 1 to 31
animals with an average of 7.4 animals per sibship.
The rate of melanoma at birth observed in these pedigrees
was 0.407 (252/619 animals). SLA haplotype data were
available for 374 animals. The observed haplotype distribu-
tion was 40 XX, 126 BX and 208BB. Because of the high
degree of non-independence due to pedigree relationships, we
chose to estimate the frequency of the B haplotype
simultaneously with our other segregation analysis para-
meters.
Segregation analysis
Table II shows the results of our two-locus complex
segregation analysis. All models could be unequivocally
rejected except for the two-locus model incorporating both
a major gene and the SLA locus. For the unknown major
locus (the A locus) estimated transmission probabilities
Table I Distribution of animals by pedigree
Animals assessed
Pedigree Total animals for melanoma
1 237 195
2 221 191
3 79 60
4 61 53
5 39 28
6 36 27
7 31 25
8 21 16
9 14 7
10 13 8
11 10 7
12 4 2
Total 766 619Genetic determinants of SSCM
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Table II Two-locus segregation analysis of SSCM
Major locus
transmission SLA locus Residualparental
Model parameters effect transmission X2a df. P
General Arbitrary Yes Yes - - -
Environmental Random Yes Yes 12.74 3 0.005
Major locus+SLA locus Mendelian Yes Yes 0.66 3 0.883
Major locus Mendelian No Yes 25.31 9 0.003
SLA locus None Yes Yes 32.61 10 0.0003
Familial None No Yes 48.86 12 <0.0001
Sporadic None No No 70.90 14 <0.0001
a x2 tests refer to comparisons with the most general model.
(TAA= 1.00 ZAa =0.35, .aa =0.00) were not significantly
different from Mendelian expectations (TAA= 1, TAa= 1/2,
Taa =0) as judged by a likelihood ratio test. The environ-
mental hypothesis in which major factor transmission is
independent of parental phenotype was rejected (X23 = 12.74,
P=0.005), indicating the major locus transmission is
necessary to adequately account for the data. The single-
locus models allowing for only the effect of the unknown
major gene could be rejected as could a model in which only
the SLA locus influenced melanoma risk. These results
provide clear evidence for two loci jointly influencing risk
of SSCM.
Additional statistical evaluation of genetic models
indicated that there was no evidence of epistasis (X24=6.86,
P=0.143) and that a dominant model for the major locus
provided an excellent fit to the observed data (X21 =0.16,
P=0.689). However, the hypothesis that the SLA locus
influenced SSCM risk in a dominant fashion was rejected
(X21 =6.08, P=0.014). Therefore the most parsimonious two-
locus model included a dominant major locus and a co-
dominant locus segregating with the SLA complex.
Linkage and gametic disequilibrium analysis
To examine the potential for co-segregation of the major
locus with the SLA locus we performed a linkage analysis in
which the recombination fraction (0) between loci was
estimated. This analysis also incorporated the estimation of
standardised gametic disequilibrium (D') to allow for non-
independence among loci due to the effects of historical
population structure even in the absence of linkage.
Additionally, all other parameters (gene frequency and
penetrance parameters) were simultaneously estimated in
this combined segregation and linkage analysis.
Figure 1 shows the profile lod score function obtained
from the linkage analysis. The limits of the y-axis are those
expected for acceptance of a hypothesis oflinkage (lod =3) or
rejection of a particular recombination fraction (lod = -2).
Although the estimated recombination fraction was 0.145, the
maximum lod score was only 0.536, indicating little support
for the hypothesis of linkage. However, as Figure 1 indicates,
we also have no evidence for rejecting linkage at any
recombination fraction. Thus, the current data provide little
power for determining linkage between these two loci.
Although we found no evidence of linkage, the estimated
standardised gametic disequilibrium value ('=-0.67+
0.31) was significant (X21=4.0, P=0.046). In the absence of
clear evidence for linkage, we attribute this apparent non-
independence between loci as the likely result of selective
breeding for the B haplotype in combination with the relative
rarity of the dominant a allele (whose estimated frequency
was 0.127+0.034 at the major locus). In this combined
analysis, the estimated frequency of the B haplotype at the
SLA locus was 0.617+0.039.
Penetrance estimates
Penetrance estimates for each two-locus genotype and their
standard errors are provided in Table III. These estimates
were obtained via transformation of the original estimated
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Figure 1 Profile lod score function for assessing linkage between
the unknown major locus and the SLA locus. The maximum
likelihood estimate of the recombination fraction is noted by the
arrow.
TableIII Estimated penetrances for the most parsimonious two-locus
model
Major locus SLA locus
genotype genotype Frequency Penetrance
AA XX 0.080 0.000±0.003
AA BX 0.333 0.167±0.043
AA BB 0.349 0.372+0.062
Aa XX 0.057 0.753 +0.049
Aa BX 0.134 1.000±0.003
Aa BB 0.031 1.000+ 0.003
aa XX 0.010 0.753+0.049
aa BX 0.005 1.000+0.003
aa BB 0.001 1.000+ 0.003
penetrance parameters of the two-locus model and by
allowing for gametic disequilibrium. The AAXX genotype is
not at risk for developing SSCM, while genotypes with at
least one a allele at the major locus and at least one B
haplotype at the SLA locus exhibit complete penetrance. The
major locus has the greatest effect on overall risk and may
represent a tumour-initiator locus. The B haplotype at the
SLA locus serves to modify the penetrance.
Genetic effects on tumour burden
Given our most parsimonious two-locus model allowing for
gametic disequilibrium, we calculated the posterior probabil-
ities of each two-locus genotype for each animal. These
posterior probabilities were used to estimate the effects of the
two loci on tumour burden, an index of severity. Figure 2
illustrates the tumour distribution in the 297 animals for
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Figure 2 Distribution of tumour burden, an index of severity, in
297 animals.
whom the requisite data were available. Mean tumour burden
was 1.25 in these animals. The observed distribution does not
fit a Poisson distribution due to significant evidence for
overdispersion (the variance is approximately three times
larger than the mean), which may be the result ofvariation at
the two hypothesised loci.
Figure 3 shows the relationship between tumour burden
and two-locus phenotypes. Clearly, genetic variation has an
important influence on this measure of disease severity. The
two loci jointly explain a significant proportion (21.2 +2.9%)
of the total variation in tumour burden.
Discussion
We have established that two loci jointly determine the risk
of SSCM in our pedigrees. Our unknown major locus may
represent a tumour-initiator or -suppressor gene responsible
for SSCM initiation. The other locus is found in (or co-
segregates with) the SLA complex and is responsible for
modifying penetrance at the initiator locus. Since the major
histocompatability complex has an important role in the
immune response of all mammalian species, our finding of an
SLA association with risk of melanoma implies that research
on immunological factors needs to be further pursued.
Questions regarding whether a specific immune mechanism
is involved in melanoma initiation also need to be addressed.
Unlike the genetic analysis of CMM in human pedigrees
SSCM is not likely to express genetic heterogeneity since it
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Figure 3 Effects of the two-locus genotypes on quantitative
tumour burden. Error bars indicate +1 s.e.m.
arose in a single family within a genetically isolated herd. In
this study all SSCM cases could be traced paternally to the
descendants of a single founding boar or the male offspring
of a single gilt. Additionally, our large swine pedigrees appear
to be superior to most human pedigrees for resolving
oligogenic forms of inheritance.
Having documented the two-locus inheritance of SSCM
our next goal is to map the unknown major locus.
Cytogenetic abnormalities in SSCM cell lines have been
identified for chromosome regions 2p and 2q (syntenic to
human chromosome llp), 6q (syntenic to human chromo-
some 19q), 13 (syntenic to 3q and 13q) and 14 (syntenic to 8p
and 10q) (Green et al., 1992; Rohrer et al., 1994) and suggest
potential candidate regions for future linkage analyses. Our
recent progress in porcine gene mapping has generated the
most complete genetic linkage information for a livestock
species to date (Rohrer et al., 1994). Nearly 400 microsatellite
loci in 24 linkage groups that cover approximately 2000 cM
have been mapped. We intend to use these and additional
microsatellite markers in a systematic genomic search for the
tumour-initiator (-suppressor) locus.
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